BIT 0.00% 3.9¢ biotron limited

Ann: Presentation to Investors, page-21

  1. 124 Posts.
    lightbulb Created with Sketch. 20
    We can agree to disagree here - of course the data will be presented to any prospective partner that will agree to take a meeting with BIT.  The key here is that did the data met the 'primary endpoint' and if not any 'secondary endpoint' of the trial.


    I can reel off countless instances on ASX of companies releasing data that they put a positive spin on (let's call that positive news) but it didn't meet the 'endpoints' and never once did the market react favorably - in most cases the market was quite brutal in its response.  Just take a look at ACL in late October 2014 and NEU this year alone.


    I am just being devils advocate here as it appears that most long this grasp endlessly at anything that affirms their 'confirmation bias'


    We will all know in due course



 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
0.000(0.00%)
Mkt cap ! $35.18M
Open High Low Value Volume
3.9¢ 3.9¢ 3.8¢ $1.335K 34.62K

Buyers (Bids)

No. Vol. Price($)
4 1131315 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 330372 2
View Market Depth
Last trade - 15.04pm 09/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.